Home Cancer Biomarker Products Mitochondrial Targets for Metabolic Disease - BioMosaics Inc.
OVERVIEW
BIOMOSAICS.COM RANKINGS
Date Range
Date Range
Date Range
BIOMOSAICS.COM HISTORY
BUSINESS PERIOD OF EXISTANCE
LINKS TO WEB SITE
Vector Laboratories - Reducing Tissue Autofluorescence Tutorial.
WHAT DOES BIOMOSAICS.COM LOOK LIKE?
CONTACTS
PERFECT PRIVACY, LLC
12808 Gran Bay Parkway West
Jacksonville, FL, 32258
US
PERFECT PRIVACY, LLC
12808 Gran Bay Parkway West
Jacksonville, FL, 32258
US
BIOMOSAICS.COM HOST
NAME SERVERS
PAGE TITLE
Home Cancer Biomarker Products Mitochondrial Targets for Metabolic Disease - BioMosaics Inc.DESCRIPTION
Cancer Biomarker Products Mitochondrial Targets for Metabolic Disease. Search our catalog of Research and Diagnostic products. BioMosaics has received a Phase 0 SBIR Award through the Vermont Experimental Program to Stimulate Competitive Research EPSCoR to develp therapeutics directed at the MCJ mitochondrial target.CONTENT
This web page states the following, "Cancer Biomarker Products Mitochondrial Targets for Metabolic Disease." We viewed that the web site said " Search our catalog of Research and Diagnostic products." It also said " BioMosaics has received a Phase 0 SBIR Award through the Vermont Experimental Program to Stimulate Competitive Research EPSCoR to develp therapeutics directed at the MCJ mitochondrial target."VIEW SUBSEQUENT BUSINESSES
Als camps del Poble Nou de Benitatxell. BioMoscatell, el projecte del raïm de moscatell ecològic.
Graham Park Stream and Wetland Restoration. Abandoned mine drainage impacts thousands of miles of streams in Pennsylvania and elsewhere.
Další várka bude k prodeji až na podzim. Během vánočních svátků máme zavřeno. Stvolny 16, 331 62 Manětín. 725 552 919 Jaroslav Hruška. 728 039 399 Miroslava Hrušková. Každý den včetně víkendů a svátků. Bydlíme naproti v roubence, můžete zazvonit i po otevírací době.
At the edge of cancer research. The immune system against tumours. For patients, families and friends. Davidson Ateh is an entrepreneurial executive with a successful track record of managing and financing disruptive early stage technology projects. He is the CEO of BioMoti where he raised over 1. 5 million in non-dilutive and risk capital including securing a number of alliances.